Weekly IC Summary - 2026-05-03
Two high-conviction ADD recommendations this week: LLY upgraded on breakthrough retatrutide Phase 3 data showing 37-pound average weight loss, and FXY on Japan's catalytic leadership change triggering yen revaluation.
- Two high-conviction ADD recommendations this week: LLY upgraded on breakthrough retatrutide Phase 3 data showing 37-pound average weight loss, and FXY on Japan's catalytic leadership change triggering yen revaluation.
- Multiple HOLD ratings reflect strong fundamentals but valuation/technical concerns across mega-cap tech (GOOGL, MSFT, META) amid persistent insider selling.
- WDAY receives REDUCE rating as heavy insider selling validates platform disruption risk from AI-native competitors.
- Portfolio expansion focused on transformational healthcare breakthrough (LLY) and macro catalyst trade (FXY) while maintaining defensive posture in overvalued tech.
- Member access required
- Member access required
- Member access required
No watchlist items provided.
Unlock Weekly IC Summary
Get full conviction changes, risk signals, and portfolio adjustments.
One click with SSO. Takes seconds.
Email sign-in is temporarily unavailable. Continue with Google or Microsoft.